FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3091996716> ?p ?o ?g. }

• W3091996716 endingPage "1468" @default.
• W3091996716 startingPage "1461" @default.
• W3091996716 abstract "Objective Human epididymis protein 4 (HE4) is a validated, complementary biomarker to cancer antigen 125 (CA125) for high grade serous ovarian carcinoma (HGSC). Currently, there are insufficient data on the utility of longitudinal HE4 measurement during HGSC treatment and follow up. We set to provide a comprehensive analysis on the kinetics and prognostic performance of HE4 with serial measurements during HGSC treatment and follow up.Methods This prospective study included 143 patients with advanced HGSC (ClinicalTrials.gov identifier: NCT01276574). Serum CA125 and HE4 were measured at baseline, before each cycle of chemotherapy and during follow up until first progression. Baseline biomarker values were compared to the tumor load assessed during surgery and to residual disease. Biomarker nadir values and concentrations at progression were correlated to survival.Results The baseline HE4 concentration distinguished patients with a high tumor load from patients with a low tumor load assessed during surgery (p<.0001). The baseline CA125 level was not associated with tumor load to a similar extent (p=.067). At progression, the HE4 level was an independent predictor of worse survival in the multivariate analysis (p=.002). All patients that were alive 3 years post-progression had a serum HE4 concentration below 199.20 pmol/l at the 1st recurrence.Conclusion HE4 is a feasible biomarker in the treatment monitoring and prognostic stratification of patients with HGSC. Specifically, the serum level of HE4 at first relapse was associated with the survival of patients and it may be a useful complementary tool in the selection of second line treatments. This is to the best of our knowledge the first time this finding has been reported." @default.
• W3091996716 created "2020-10-15" @default.
• W3091996716 creator A5017337687 @default.
• W3091996716 creator A5030148031 @default.
• W3091996716 creator A5043341222 @default.
• W3091996716 creator A5044104350 @default.
• W3091996716 creator A5046028525 @default.
• W3091996716 creator A5075537648 @default.
• W3091996716 creator A5081022486 @default.
• W3091996716 creator A5090360946 @default.
• W3091996716 date "2020-10-08" @default.
• W3091996716 modified "2023-10-15" @default.
• W3091996716 title "HE4 in the evaluation of tumor load and prognostic stratification of high grade serous ovarian carcinoma" @default.
• W3091996716 cites W1969121873 @default.
• W3091996716 cites W1981559854 @default.
• W3091996716 cites W1983275362 @default.
• W3091996716 cites W1991490883 @default.
• W3091996716 cites W1993928534 @default.
• W3091996716 cites W2002710053 @default.
• W3091996716 cites W2028397492 @default.
• W3091996716 cites W2029112222 @default.
• W3091996716 cites W2039785378 @default.
• W3091996716 cites W2058484951 @default.
• W3091996716 cites W2104072698 @default.
• W3091996716 cites W2110301491 @default.
• W3091996716 cites W2116553945 @default.
• W3091996716 cites W2119756779 @default.
• W3091996716 cites W2126280475 @default.
• W3091996716 cites W2129940924 @default.
• W3091996716 cites W2148495545 @default.
• W3091996716 cites W2151178437 @default.
• W3091996716 cites W2158679766 @default.
• W3091996716 cites W2166023752 @default.
• W3091996716 cites W2291806982 @default.
• W3091996716 cites W2590662800 @default.
• W3091996716 cites W2765797716 @default.
• W3091996716 cites W2796850570 @default.
• W3091996716 cites W2802074519 @default.
• W3091996716 cites W2807649309 @default.
• W3091996716 cites W2885715636 @default.
• W3091996716 cites W2902199239 @default.
• W3091996716 cites W2943306812 @default.
• W3091996716 cites W2989875905 @default.
• W3091996716 cites W3007373686 @default.
• W3091996716 cites W4255462147 @default.
• W3091996716 cites W97046790 @default.
• W3091996716 doi "https://doi.org/10.1080/0284186x.2020.1827157" @default.
• W3091996716 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33030975" @default.
• W3091996716 hasPublicationYear "2020" @default.
• W3091996716 type Work @default.
• W3091996716 sameAs 3091996716 @default.
• W3091996716 citedByCount "10" @default.
• W3091996716 countsByYear W30919967162021 @default.
• W3091996716 countsByYear W30919967162022 @default.
• W3091996716 countsByYear W30919967162023 @default.
• W3091996716 crossrefType "journal-article" @default.
• W3091996716 hasAuthorship W3091996716A5017337687 @default.
• W3091996716 hasAuthorship W3091996716A5030148031 @default.
• W3091996716 hasAuthorship W3091996716A5043341222 @default.
• W3091996716 hasAuthorship W3091996716A5044104350 @default.
• W3091996716 hasAuthorship W3091996716A5046028525 @default.
• W3091996716 hasAuthorship W3091996716A5075537648 @default.
• W3091996716 hasAuthorship W3091996716A5081022486 @default.
• W3091996716 hasAuthorship W3091996716A5090360946 @default.
• W3091996716 hasBestOaLocation W30919967161 @default.
• W3091996716 hasConcept C121608353 @default.
• W3091996716 hasConcept C126322002 @default.
• W3091996716 hasConcept C143998085 @default.
• W3091996716 hasConcept C150173356 @default.
• W3091996716 hasConcept C185592680 @default.
• W3091996716 hasConcept C188816634 @default.
• W3091996716 hasConcept C2777632260 @default.
• W3091996716 hasConcept C2780427987 @default.
• W3091996716 hasConcept C2781197716 @default.
• W3091996716 hasConcept C2992389814 @default.
• W3091996716 hasConcept C3019054536 @default.
• W3091996716 hasConcept C50382708 @default.
• W3091996716 hasConcept C55493867 @default.
• W3091996716 hasConcept C71924100 @default.
• W3091996716 hasConceptScore W3091996716C121608353 @default.
• W3091996716 hasConceptScore W3091996716C126322002 @default.
• W3091996716 hasConceptScore W3091996716C143998085 @default.
• W3091996716 hasConceptScore W3091996716C150173356 @default.
• W3091996716 hasConceptScore W3091996716C185592680 @default.
• W3091996716 hasConceptScore W3091996716C188816634 @default.
• W3091996716 hasConceptScore W3091996716C2777632260 @default.
• W3091996716 hasConceptScore W3091996716C2780427987 @default.
• W3091996716 hasConceptScore W3091996716C2781197716 @default.
• W3091996716 hasConceptScore W3091996716C2992389814 @default.
• W3091996716 hasConceptScore W3091996716C3019054536 @default.
• W3091996716 hasConceptScore W3091996716C50382708 @default.
• W3091996716 hasConceptScore W3091996716C55493867 @default.
• W3091996716 hasConceptScore W3091996716C71924100 @default.
• W3091996716 hasIssue "12" @default.
• W3091996716 hasLocation W30919967161 @default.
• W3091996716 hasLocation W30919967162 @default.
• W3091996716 hasOpenAccess W3091996716 @default.
• W3091996716 hasPrimaryLocation W30919967161 @default.

• next